{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:28Z","timestamp":1792783528140,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10270022110004"],"award-info":[{"award-number":["10270022110004"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amsterdam UMC Foundation Young Talent Fund","id":[{"id":"https:\/\/ror.org\/05grdyy37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Research Council of Thailand","award":["N42A690510"],"award-info":[{"award-number":["N42A690510"]}],"id":[{"id":"https:\/\/ror.org\/018wfhg78","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"DOI":"10.1007\/s40273-026-01665-6","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:21:32Z","timestamp":1790749292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Meta-Analysis of Incremental Net Benefit from Trial-Based Health Economic Evaluations in R: A Tutorial"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4621-4077","authenticated-orcid":false,"given":"Romain Jonathan","family":"Collet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Maria","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oraluck","family":"Pattanaprateep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suparee Wisawapipat","family":"Boonmanunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardine","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Ekkina","family":"Bosmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Coup\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Ostelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammarin","family":"Thakkinstian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"6","key":"1665_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1017\/S0266462318000624","volume":"34","author":"M Luhnen","year":"2018","unstructured":"Luhnen M, Prediger B, Neugebauer EAM, Mathes T. Systematic reviews of economic evaluations in health technology assessment: a review of characteristics and applied methods. Int J Technol Assess Health Care. 2018;34(6):537\u201346.","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"1665_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jval.2021.01.002","volume":"24","author":"OL Mandrik","year":"2021","unstructured":"Mandrik OL, Severens JLH, Bardach A, Ghabri S, Hamel C, Mathes T, et al. Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report. Value Health. 2021;24(4):463\u201372.","journal-title":"Value Health"},{"issue":"1","key":"1665_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01536-6","volume":"22","author":"A Weise","year":"2022","unstructured":"Weise A, B\u00fcchter RB, Pieper D, Mathes T. Assessing transferability in systematic reviews of health economic evaluations: a review of methodological guidance. BMC Med Res Methodol. 2022;22(1):52.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1665_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/20477724.2022.2106108","volume":"117","author":"A Falkowski","year":"2023","unstructured":"Falkowski A, Ciminata G, Manca F, Bouttell J, Jaiswal N, Farhana Binti Kamaruzaman H, et al. How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathog Glob Health. 2023;117(2):104\u201319.","journal-title":"Pathog Glob Health"},{"issue":"1","key":"1665_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12962-021-00293-5","volume":"19","author":"S Hollingworth","year":"2021","unstructured":"Hollingworth S, Fenny AP, Yu SY, Ruiz F, Chalkidou K. Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis. Cost Eff Resour Alloc. 2021;19(1):39.","journal-title":"Cost Eff Resour Alloc."},{"issue":"3","key":"1665_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40273-019-00878-2","volume":"38","author":"E Jacobsen","year":"2020","unstructured":"Jacobsen E, Boyers D, Avenell A. Challenges of systematic reviews of economic evaluations: a review of recent reviews and an obesity case study. Pharmacoeconomics. 2020;38(3):259\u201367.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1665_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1524-4733.2008.00489.x","volume":"12","author":"M Drummond","year":"2009","unstructured":"Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 2009;12(4):409\u201318.","journal-title":"Value Health."},{"issue":"1","key":"1665_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13643-020-01536-x","volume":"9","author":"GE Shields","year":"2020","unstructured":"Shields GE, Elvidge J. Challenges in synthesising cost-effectiveness estimates. Syst Rev. 2020;9(1):289.","journal-title":"Syst Rev"},{"issue":"8","key":"1665_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s40273-020-00914-6","volume":"38","author":"M Paulden","year":"2020","unstructured":"Paulden M. Calculating and interpreting ICERs and net benefit. Pharmacoeconomics. 2020;38(8):785\u2013807.","journal-title":"Pharmacoeconomics"},{"issue":"2 Suppl.","key":"1665_CR10","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1177\/0272989X98018002S09","volume":"18","author":"AA Stinnett","year":"1998","unstructured":"Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2 Suppl.):S68-80.","journal-title":"Med Decis Making"},{"key":"1665_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-139","volume":"14","author":"C Crespo","year":"2014","unstructured":"Crespo C, Monleon A, D\u00edaz W, R\u00edos M. Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies. BMC Med Res Methodol. 2014;14:139.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1665_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07595-1","volume":"22","author":"BS Bagepally","year":"2022","unstructured":"Bagepally BS, Chaikledkaew U, Chaiyakunapruk N, Attia J, Thakkinstian A. Meta-analysis of economic evaluation studies: data harmonisation and methodological issues. BMC Health Serv Res. 2022;22(1):202.","journal-title":"BMC Health Serv Res"},{"key":"1665_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2025.105103","volume":"168","author":"R Collet","year":"2025","unstructured":"Collet R, Groenewoud C, Ostelo R, van Grootel J, van der Leeden M, van der Schaaf M, et al. Cost-effectiveness of multidisciplinary transitional care interventions: a systematic review and meta-analysis. Int J Nurs Stud. 2025;168:105103.","journal-title":"Int J Nurs Stud"},{"key":"1665_CR14","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015."},{"key":"1665_CR15","doi-asserted-by":"crossref","unstructured":"Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004;8(49):iii\u2013iv, 1\u2013192.","DOI":"10.3310\/hta8490"},{"issue":"13","key":"1665_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2165\/00019053-200422130-00004","volume":"22","author":"R Welte","year":"2004","unstructured":"Welte R, Feenstra T, Jager H, Leidl R. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics. 2004;22(13):857\u201376.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"1665_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.healthpol.2013.09.003","volume":"113","author":"K B\u00f6hm","year":"2013","unstructured":"B\u00f6hm K, Schmid A, G\u00f6tze R, Landwehr C, Rothgang H. Five types of OECD healthcare systems: empirical results of a deductive classification. Health Policy. 2013;113(3):258\u201369.","journal-title":"Health Policy"},{"key":"1665_CR18","unstructured":"International Health Care System Profiles. 2020. Available from: https:\/\/www.commonwealthfund.org\/international-health-policy-center\/system-profiles. [Accessed 31 Aug 2026]."},{"issue":"6","key":"1665_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/14737167.2016.1246962","volume":"16","author":"FW Thielen","year":"2016","unstructured":"Thielen FW, Van Mastrigt G, Burgers LT, Bramer WM, Majoie H, Evers S, et al. How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2\/3). Expert Rev Pharmacoecon Outcomes Res. 2016;16(6):705\u201321.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"1665_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/14737167.2016.1246960","volume":"16","author":"GA van Mastrigt","year":"2016","unstructured":"van Mastrigt GA, Hiligsmann M, Arts JJ, Broos PH, Kleijnen J, Evers SM, et al. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1\/3). Expert Rev Pharmacoecon Outcomes Res. 2016;16(6):689\u2013704.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"1665_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/14737167.2016.1246961","volume":"16","author":"B Wijnen","year":"2016","unstructured":"Wijnen B, Van Mastrigt G, Redekop WK, Majoie H, De Kinderen R, Evers S. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3\/3). Expert Rev Pharmacoecon Outcomes Res. 2016;16(6):723\u201332.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"9","key":"1665_CR22","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jval.2019.03.021","volume":"22","author":"HC Turner","year":"2019","unstructured":"Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for inflation and currency changes within health economic studies. Value Health. 2019;22(9):1026\u201332.","journal-title":"Value Health"},{"key":"1665_CR23","unstructured":"Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied methods of cost-effectiveness analysis in healthcare. Oxford: Oxford University Press; 2010."},{"key":"1665_CR24","unstructured":"World Development Indicators. 2026. Available from: https:\/\/databank.worldbank.org\/source\/world-development-indicators. [Accessed 31 Aug 2026]."},{"key":"1665_CR25","doi-asserted-by":"crossref","unstructured":"Harrer M, Cuijpers P, Furukawa TA, Ebert DD. Doing meta-analysis with R: a hands-on guide. 1st ed. Boca Raton (FL) and London: Chapman & Hall\/CRC Press; 2021.","DOI":"10.1201\/9781003107347"},{"key":"1665_CR26","unstructured":"National Institute for Health and Care Excellence. Changes to NICE\u2019s cost-effectiveness thresholds confirmed. London: National Institute for Health and Care Excellence; 2025."},{"issue":"15","key":"1665_CR27","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/jama.2023.1792","volume":"329","author":"PJ Neumann","year":"2023","unstructured":"Neumann PJ, Kim DD. Cost-effectiveness thresholds used by study authors, 1990\u20132021. JAMA. 2023;329(15):1312\u20134.","journal-title":"JAMA"},{"issue":"5","key":"1665_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40273-017-0606-1","volume":"36","author":"P Thokala","year":"2018","unstructured":"Thokala P, Ochalek J, Leech AA, Tong T. Cost-effectiveness thresholds: the past, the present and the future. Pharmacoeconomics. 2018;36(5):509\u201322.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1665_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jval.2021.08.003","volume":"25","author":"M Schurer","year":"2022","unstructured":"Schurer M, Matthijsse SM, Vossen CY, van Keep M, Horscroft J, Chapman AM, et al. Varying willingness to pay based on severity of illness: impact on health technology assessment outcomes of inpatient and outpatient drug therapies in the Netherlands. Value Health. 2022;25(1):91\u2013103.","journal-title":"Value Health."},{"issue":"1","key":"1665_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Value Health. 2022;25(1):3\u20139.","journal-title":"Value Health"},{"key":"1665_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"issue":"4","key":"1665_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1586\/14737167.2015.1103185","volume":"16","author":"CC Adarkwah","year":"2016","unstructured":"Adarkwah CC, van Gils PF, Hiligsmann M, Evers SM. Risk of bias in model-based economic evaluations: the ECOBIAS checklist. Expert Rev Pharmacoecon Outcomes Res. 2016;16(4):513\u201323.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"1665_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Sch\u00fcnemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380\u20132.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1665_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0618-3","volume":"19","author":"SE Seide","year":"2019","unstructured":"Seide SE, R\u00f6ver C, Friede T. Likelihood-based random-effects meta-analysis with few studies: empirical and simulation studies. BMC Med Res Methodol. 2019;19(1):16.","journal-title":"BMC Med Res Methodol"},{"issue":"6-7","key":"1665_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/sim.70352","volume":"45","author":"H Bang","year":"2026","unstructured":"Bang H, Zhao H. Meta-analysis of cost-effectiveness. Stat Med. 2026;45(6\u20137):e70352.","journal-title":"Stat Med"},{"issue":"10-12","key":"1665_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/sim.70575","volume":"45","author":"GL Di Tanna","year":"2026","unstructured":"Di Tanna GL, Meier N, Schwenkglenks M. Comment on \u201cMeta-analysis of cost-effectiveness\u201d by Bang and Zhao: combinability, joint modeling, and a two-stage framework for cost-effectiveness analysis synthesis. Stat Med. 2026;45(10\u201312):e70575.","journal-title":"Stat Med"},{"issue":"12","key":"1665_CR37","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/hec.4603","volume":"31","author":"M El Alili","year":"2022","unstructured":"El Alili M, van Dongen JM, Esser JL, Heymans MW, van Tulder MW, Bosmans JE. A scoping review of statistical methods for trial-based economic evaluations: the current state of play. Health Econ. 2022;31(12):2680\u201399.","journal-title":"Health Econ"},{"key":"1665_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jclinepi.2018.01.013","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Alonso-Coello P, Guyatt GH, Yepes-Nu\u00f1ez JJ, Akl EA, Hazlewood G, et al. GRADE guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences \u2014 risk of bias and indirectness. J Clin Epidemiol. 2019;111:94\u2013104.","journal-title":"J Clin Epidemiol"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-026-01665-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:02:42Z","timestamp":1790809362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-026-01665-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":38,"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1007\/s40273-026-01665-6","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by ZonMw (Grant Number 10270022110004), the Amsterdam UMC Foundation Young Talent Fund, and the National Research Council of Thailand (Grant Number N42A690510).","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Romain Jonathan Collet, Johanna Maria van Dongen, Oraluck Pattanaprateep, Suparee Wisawapipat Boonmanunt, Ardine de Wit, Judith Ekkina Bosmans, Veerle Coup\u00e9, Raymond Ostelo, and Ammarin Thakkinstian have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","label":"Conflicts of Interest\/Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study materials can be downloaded from\n                      \n                      .","order":6,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualisation: all authors; data curation: RJC; formal analysis: RJC, JMvD, JEB; funding acquisition: RJC, RO; methodology: RJC, JMvD, JEB, RO, AT; project administration: RJC; software: RJC; supervision: JMvD, AT; validation: JMvD, JEB, OP; visualisation: RJC; writing (original draft): RJC; writing (review and editing): all authors.","order":8,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}